| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/09/2023 | 49.05% | JP Morgan | $17 → $16.5 | Maintains | Overweight |
| 07/11/2023 | 35.5% | Wells Fargo | $14 → $15 | Maintains | Overweight |
| 05/25/2023 | 17.43% | Piper Sandler | $21 → $13 | Maintains | Overweight |
| 05/15/2023 | 30.98% | Credit Suisse | $14 → $14.5 | Maintains | Neutral |
| 05/11/2023 | 26.47% | Wells Fargo | $16 → $14 | Maintains | Overweight |
| 04/19/2023 | 44.53% | Morgan Stanley | $20 → $16 | Maintains | Overweight |
| 02/21/2023 | 35.5% | Credit Suisse | $14 → $15 | Maintains | Neutral |
| 01/24/2023 | 80.67% | Morgan Stanley | $21 → $20 | Maintains | Overweight |
| 01/11/2023 | 62.6% | Wells Fargo | $19 → $18 | Maintains | Overweight |
| 11/15/2022 | 44.53% | UBS | $15 → $16 | Maintains | Neutral |
| 10/19/2022 | 89.7% | Morgan Stanley | $22 → $21 | Maintains | Overweight |
| 10/19/2022 | 35.5% | Credit Suisse | → $15 | Initiates Coverage On | → Neutral |
| 08/12/2022 | 98.74% | Morgan Stanley | $21 → $22 | Maintains | Overweight |
| 08/10/2022 | 89.7% | Wells Fargo | $19 → $21 | Maintains | Overweight |
| 07/19/2022 | 89.7% | Morgan Stanley | $26 → $21 | Maintains | Overweight |
| 07/13/2022 | 71.64% | Wells Fargo | $22 → $19 | Maintains | Overweight |
| 05/17/2022 | 134.87% | Morgan Stanley | $25 → $26 | Maintains | Overweight |
| 04/20/2022 | 125.84% | Morgan Stanley | $26 → $25 | Maintains | Overweight |
| 04/19/2022 | 98.74% | Wells Fargo | $24 → $22 | Maintains | Overweight |
| 04/12/2022 | 116.8% | Citigroup | $25 → $24 | Maintains | Buy |
| 03/08/2022 | 125.84% | Citigroup | $28 → $25 | Maintains | Buy |
| 12/17/2021 | 152.94% | Citigroup | $27 → $28 | Maintains | Buy |
| 08/20/2021 | 98.74% | Morgan Stanley | $21 → $22 | Maintains | Overweight |
| 08/10/2021 | 44.53% | UBS | → $16 | Initiates Coverage On | → Neutral |
| 08/10/2021 | 89.7% | Morgan Stanley | → $21 | Initiates Coverage On | → Overweight |
| 08/10/2021 | 71.64% | Wells Fargo | → $19 | Initiates Coverage On | → Overweight |
| 08/10/2021 | 62.6% | JP Morgan | → $18 | Initiates Coverage On | → Overweight |
What is the target price for Bridge Investment Group (BRDG)?
The latest price target for Bridge Investment Group (NYSE: BRDG) was reported by JP Morgan on August 9, 2023. The analyst firm set a price target for $16.50 expecting BRDG to rise to within 12 months (a possible 49.05% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bridge Investment Group (BRDG)?
The latest analyst rating for Bridge Investment Group (NYSE: BRDG) was provided by JP Morgan, and Bridge Investment Group maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Bridge Investment Group (BRDG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bridge Investment Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bridge Investment Group was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.
Is the Analyst Rating Bridge Investment Group (BRDG) correct?
While ratings are subjective and will change, the latest Bridge Investment Group (BRDG) rating was a maintained with a price target of $17.00 to $16.50. The current price Bridge Investment Group (BRDG) is trading at is $11.07, which is out of the analyst's predicted range.